
Transcutaneous Electrical Nerve Stimulation Market by Surgery Procedures (Direct Nerve Repair, Nerve Grafting, Stem Cell Therapy), Product (Desktop, Portable), End User - Global Forecast 2024-2030
Description
Transcutaneous Electrical Nerve Stimulation Market by Surgery Procedures (Direct Nerve Repair, Nerve Grafting, Stem Cell Therapy), Product (Desktop, Portable), End User - Global Forecast 2024-2030
The Transcutaneous Electrical Nerve Stimulation Market size was estimated at USD 336.69 million in 2023 and expected to reach USD 348.82 million in 2024, at a CAGR 3.69% to reach USD 434.08 million by 2030.
Global Transcutaneous Electrical Nerve Stimulation Market
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Transcutaneous Electrical Nerve Stimulation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Transcutaneous Electrical Nerve Stimulation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Transcutaneous Electrical Nerve Stimulation Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aleva Neurotherapeutics SA, BioMedical Life Systems, Bioness, Inc., Boston Scientific Corporation, Chirag Electronics Private Limited, S.m.r.a, Cochlear Ltd, Cogentix Medical, Inc., Cyberonics, Inc., DJO LLC., ElectroCore, Inc., EMS Physio Ltd, Medtronic plc, NeuroMetrix, Inc., NeuroPace Inc, Nevro Corp, OMRON Corporation, R-slimming Medical Systems, Uroplasty, Inc., and Zynex Medical.
Market Segmentation & Coverage
This research report categorizes the Transcutaneous Electrical Nerve Stimulation Market to forecast the revenues and analyze trends in each of the following sub-markets:
Surgery Procedures
Direct Nerve Repair
Nerve Grafting
Stem Cell Therapy
Product
Desktop
Portable
End User
Clinics
Hospital
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Transcutaneous Electrical Nerve Stimulation Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Transcutaneous Electrical Nerve Stimulation Market?
3. What are the technology trends and regulatory frameworks in the Transcutaneous Electrical Nerve Stimulation Market?
4. What is the market share of the leading vendors in the Transcutaneous Electrical Nerve Stimulation Market?
5. Which modes and strategic moves are suitable for entering the Transcutaneous Electrical Nerve Stimulation Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
186 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Transcutaneous Electrical Nerve Stimulation Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising popularity of muscle stimulators among physiotherapists
- 5.1.1.2. Increasing emphasis on pain management therapies in sports medicine
- 5.1.1.3. Rising prevalence of musculoskeletal disorders among citizens
- 5.1.2. Restraints
- 5.1.2.1. Increased cost of nerve stimulation therapy
- 5.1.3. Opportunities
- 5.1.3.1. Rising technological advancements and modernization in the machinery used in healthcare sector
- 5.1.3.2. Rising research and development activities in the healthcare sector
- 5.1.4. Challenges
- 5.1.4.1. Lack of skilled or trained physicians
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Transcutaneous Electrical Nerve Stimulation Market, by Surgery Procedures
- 6.1. Introduction
- 6.2. Direct Nerve Repair
- 6.3. Nerve Grafting
- 6.4. Stem Cell Therapy
- 7. Transcutaneous Electrical Nerve Stimulation Market, by Product
- 7.1. Introduction
- 7.2. Desktop
- 7.3. Portable
- 8. Transcutaneous Electrical Nerve Stimulation Market, by End User
- 8.1. Introduction
- 8.2. Clinics
- 8.3. Hospital
- 9. Americas Transcutaneous Electrical Nerve Stimulation Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Transcutaneous Electrical Nerve Stimulation Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Transcutaneous Electrical Nerve Stimulation Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Abbott Laboratories
- 13.1.2. Aleva Neurotherapeutics SA
- 13.1.3. BioMedical Life Systems
- 13.1.4. Bioness, Inc.
- 13.1.5. Boston Scientific Corporation
- 13.1.6. Chirag Electronics Private Limited, S.m.r.a
- 13.1.7. Cochlear Ltd
- 13.1.8. Cogentix Medical, Inc.
- 13.1.9. Cyberonics, Inc.
- 13.1.10. DJO LLC.
- 13.1.11. ElectroCore, Inc.
- 13.1.12. EMS Physio Ltd
- 13.1.13. Medtronic plc
- 13.1.14. NeuroMetrix, Inc.
- 13.1.15. NeuroPace Inc
- 13.1.16. Nevro Corp
- 13.1.17. OMRON Corporation
- 13.1.18. R-slimming Medical Systems
- 13.1.19. Uroplasty, Inc.
- 13.1.20. Zynex Medical
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET RESEARCH PROCESS
- FIGURE 2. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2023 VS 2030
- FIGURE 3. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET DYNAMICS
- FIGURE 7. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2023 VS 2030 (%)
- FIGURE 8. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 10. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
- FIGURE 12. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.